or Try an Advanced Search...

    Technical Analysis for BTAI - BioXcel Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 0.64 -3.55% -0.02
    BTAI closed down 3.55 percent on Friday, November 1, 2024, on 57 percent of normal volume.
    Earnings due: Nov 12
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical BTAI trend table...
    Date Alert Name Type % Chg
    Upper Bollinger Band Walk Strength 0.00%
    Wide Bands Range Expansion 0.00%
    Stochastic Sell Signal Bearish -3.55%
    Upper Bollinger Band Walk Strength -3.55%
    Wide Bands Range Expansion -3.55%
    Overbought Stochastic Strength -3.55%
    Upper Bollinger Band Touch Strength -3.55%
    Shooting Star Candlestick Bearish -9.93%
    Lizard Bearish Bearish Day Trade Setup -9.93%
    Pocket Pivot Bullish Swing Setup -9.93%
    Older End-of-Day Signals for BTAI ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 18 hours ago
    Down 2 % about 18 hours ago
    60 Minute Opening Range Breakdown about 18 hours ago
    Possible NR7 about 19 hours ago
    Possible Inside Day about 19 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BTAI Chart by TradingView
    Basic chart:

    Profile

    BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Artificial Intelligence Neuroscience Drug Development Cybernetics Computational Neuroscience

    Is BTAI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 29 BioXcel Therapeutics to Present at ThinkEquity Conference
    Oct 15 BioXcel announces defense grant to UNC to fund study for treating acute stress disorder
    Oct 15 BioXcel Therapeutics Announces U.S. Department of Defense Grant to University of North Carolina to Fund Study of BXCL501 (Sublingual Dexmedetomidine) for Treating Acute Stress Disorder
    Sep 19 BioXcel ends commercial support for Igalmi as focus turns to neuro candidate
    Sep 19 BioXcel Therapeutics Announces Clinical Prioritization and Update on BXCL501 Late-Stage Programs for Agitation
    Sep 5 BioXcel Therapeutics Announces Initiation of SERENITY At-Home Pivotal Phase 3 Safety Trial of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
    Aug 30 BioXcel Therapeutics (BTAI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
    Aug 10 BioXcel Therapeutics, Inc. (BTAI) Q2 2024 Earnings Call Transcript
    Aug 7 BioXcel Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
    Aug 7 Q2 2024 BioXcel Therapeutics Inc Earnings Call
    See more BTAI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.6199
    52 Week Low 0.505
    Average Volume 488,285
    200-Day Moving Average 1.74
    50-Day Moving Average 0.60
    20-Day Moving Average 0.59
    10-Day Moving Average 0.63
    Average True Range 0.05
    RSI (14) 54.75
    ADX 19.38
    +DI 34.85
    -DI 16.86
    Chandelier Exit (Long, 3 ATRs) 0.67
    Chandelier Exit (Short, 3 ATRs) 0.67
    Upper Bollinger Bands 0.71
    Lower Bollinger Band 0.48
    Percent B (%b) 0.72
    BandWidth 38.84
    MACD Line 0.02
    MACD Signal Line 0.00
    MACD Histogram 0.015
    Fundamentals Value
    Market Cap 19.54 Million
    Num Shares 30.4 Million
    EPS -7.36
    Price-to-Earnings (P/E) Ratio -0.09
    Price-to-Sales 92.61
    Price-to-Book 3.97
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.72
    Resistance 3 (R3) 0.72 0.71 0.70
    Resistance 2 (R2) 0.71 0.69 0.70 0.70
    Resistance 1 (R1) 0.67 0.68 0.67 0.67 0.70
    Pivot Point 0.66 0.66 0.65 0.65 0.66
    Support 1 (S1) 0.63 0.64 0.62 0.62 0.59
    Support 2 (S2) 0.61 0.63 0.60 0.59
    Support 3 (S3) 0.58 0.61 0.58
    Support 4 (S4) 0.57